| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 2.804 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 1.283 | 1.331 | 814 | 665 | 545 | 677 | 545 | 303 | 121 | 127 |
| Gross Profit/Loss - EUR | -1.283 | -1.331 | -814 | -665 | 2.259 | -677 | -545 | -303 | -121 | -127 |
| Net Profit/Loss - EUR | -1.283 | -1.331 | -814 | -665 | 2.180 | -677 | -545 | -303 | -121 | -127 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Goodwill Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 186 | 184 | 181 | 177 | 174 | 171 | 167 | 167 | 167 | 166 |
| Current Assets | 1.076 | 1.960 | 1.113 | 547 | 296 | 214 | 962 | 662 | 539 | 357 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1.076 | 1.960 | 1.113 | 547 | 296 | 214 | 962 | 662 | 539 | 357 |
| Shareholders Funds | 967 | -375 | -1.182 | -1.825 | 390 | -294 | -832 | -1.138 | -1.255 | -1.427 |
| Social Capital | 2.250 | 2.227 | 2.189 | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | 294 | 2.518 | 2.475 | 2.549 | 80 | 678 | 1.961 | 1.967 | 1.961 | 1.950 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Goodwill Pharma Srl